{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:17:43Z","timestamp":1794655063505,"version":"4.9.1"},"reference-count":188,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.biopha.2024.116329","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:26:09Z","timestamp":1708647969000},"page":"116329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Exploring clinical applications and long-term effectiveness of benzodiazepines: An integrated perspective on mechanisms, imaging, and personalized medicine"],"prefix":"10.1016","volume":"173","author":[{"given":"Yiheng","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueting","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meichen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2024.116329_bib1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tins.2011.01.004","article-title":"Hooked on benzodiazepines: GABAA receptor subtypes and addiction","volume":"34","author":"Tan","year":"2011","journal-title":"Trends Neurosci."},{"issue":"5","key":"10.1016\/j.biopha.2024.116329_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000524400","article-title":"Benzodiazepines remain important therapeutic options in psychiatric practice","volume":"91","author":"Dubovsky","year":"2022","journal-title":"Psychother. Psychosom."},{"issue":"3","key":"10.1016\/j.biopha.2024.116329_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1192\/bjp.2020.164","article-title":"Benzodiazepines: it's time to return to the evidence","volume":"218","author":"Silberman","year":"2021","journal-title":"Br. J. Psychiatry"},{"issue":"19","key":"10.1016\/j.biopha.2024.116329_bib4","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM197411072911906","article-title":"Drug therapy. Benzodiazepines (first of two parts)","volume":"291","author":"Greenblatt","year":"1974","journal-title":"N. Engl. J. Med"},{"issue":"23","key":"10.1016\/j.biopha.2024.116329_bib5","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1056\/NEJM197412052912308","article-title":"Drug therapy. Benzodiazepines (second of two parts)","volume":"291","author":"Greenblatt","year":"1974","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2024.116329_bib6","first-page":"243","article-title":"The rise and fall and rise of benzodiazepines: a return of the stigmatized and repressed","author":"Balon","year":"2020","journal-title":"SciELO Bras."},{"issue":"3","key":"10.1016\/j.biopha.2024.116329_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/JCP.0000000000001213","article-title":"Diazepam in the elderly: looking back, ahead, and at the evidence","volume":"40","author":"Greenblatt","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib8","first-page":"90","article-title":"Side effects of treatment with benzodiazepines","volume":"22","author":"Uzun","year":"2010","journal-title":"Psychiatr. Danub."},{"issue":"2","key":"10.1016\/j.biopha.2024.116329_bib9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jamda.2019.08.006","article-title":"Cognitive outcomes of long-term benzodiazepine and related drug (BDZR) use in people living with mild to moderate Alzheimer's disease: results from NILVAD","volume":"21","author":"Dyer","year":"2020","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.biopha.2024.116329_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-3-030-94960-0_6","article-title":"A systematic review and meta-analysis of the risk of dementia associated with benzodiazepine use, after controlling for protopathic bias","author":"Mitra","year":"2022","journal-title":"Essent. Rev. Geriatr. Psychiatry"},{"issue":"6","key":"10.1016\/j.biopha.2024.116329_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2715","article-title":"Driving performance and neurocognitive skills of long-term users of benzodiazepine anxiolytics and hypnotics","volume":"34","author":"van der Sluiszen","year":"2019","journal-title":"Hum. Psychopharmacol.: Clin. Exp."},{"issue":"4","key":"10.1016\/j.biopha.2024.116329_bib12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/clpt.2011.3","article-title":"Benzodiazepine-like hypnotics and the associated risk of road traffic accidents","volume":"89","author":"Orriols","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2024.116329_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2165\/11539050-000000000-00000","article-title":"Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence","volume":"34","author":"Dassanayake","year":"2011","journal-title":"Drug Saf."},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib14","article-title":"Concordance with a stopp (screening tool of older persons\u2019potentially inappropriate prescriptions) criterion in nova scotiA","volume":"23","author":"Hill-Taylor","year":"2016","journal-title":"CANADA: BENZODIAZEPINE ZOPICLONE Prescr. CLAIMS BYOLDER ADULTS FALL-Relat. Hosp. J. Popul. Ther. Clin. Pharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116329_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238723","article-title":"Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study","volume":"15","author":"Ishibashi","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2024.116329_bib16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00002512-200825010-00007","article-title":"Benzodiazepines and injurious falls in community dwelling elders","volume":"25","author":"Pariente","year":"2008","journal-title":"Drugs Aging"},{"issue":"5","key":"10.1016\/j.biopha.2024.116329_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000524772","article-title":"Representation of benzodiazepines in treatment guidelines: the paradox of undesirable objectivity","volume":"91","author":"Starcevic","year":"2022","journal-title":"Psychother. Psychosom."},{"issue":"4","key":"10.1016\/j.biopha.2024.116329_bib18","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996\u20132013","volume":"106","author":"Bachhuber","year":"2016","journal-title":"Am. J. Public Health"},{"issue":"3","key":"10.1016\/j.biopha.2024.116329_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/2045125317743651","article-title":"Benzodiazepine prescription in Ontario residents aged 65 and over: a population-based study from 1998 to 2013","volume":"8","author":"Davies","year":"2018","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116329_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1176\/appi.ps.201800321","article-title":"Benzodiazepine use and misuse among adults in the United States","volume":"70","author":"Maust","year":"2019","journal-title":"Psychiatr. Serv."},{"issue":"4","key":"10.1016\/j.biopha.2024.116329_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jama.2020.22106","article-title":"Balancing the risks and benefits of benzodiazepines","volume":"325","author":"Hirschtritt","year":"2021","journal-title":"Jama"},{"issue":"6","key":"10.1016\/j.biopha.2024.116329_bib22","article-title":"Hazardous use of benzodiazepine receptor agonists in psychiatric clinics in China: Electronic prescription database study","volume":"8","author":"Xu","year":"2022","journal-title":"BJPsych Open"},{"issue":"2","key":"10.1016\/j.biopha.2024.116329_bib23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/10826084.2014.962047","article-title":"Nonmedical prescription drug use (NMPDU) in the Swedish general population\u2014correlates of analgesic and sedative use","volume":"50","author":"Abrahamsson","year":"2015","journal-title":"Subst. Use Misuse"},{"issue":"6","key":"10.1016\/j.biopha.2024.116329_bib24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jadohealth.2018.04.003","article-title":"Trends in the misuse of tranquilizers, sedatives, and sleeping pills by adolescents in Spain, 2004\u20132014","volume":"63","author":"Carrasco-Garrido","year":"2018","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.biopha.2024.116329_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: a systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.biopha.2024.116329_bib26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.9740\/mhc.2016.05.120","article-title":"Benzodiazepine use, misuse, and abuse: a review","volume":"6","author":"Schmitz","year":"2016","journal-title":"Ment. Health Clin."},{"key":"10.1016\/j.biopha.2024.116329_bib27","unstructured":"[Available from: \u3008https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class\u3009."},{"issue":"1-2","key":"10.1016\/j.biopha.2024.116329_bib28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: a review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.biopha.2024.116329_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pmedr.2017.12.010","article-title":"Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993\u20132014","volume":"9","author":"Hirschtritt","year":"2018","journal-title":"Prev. Med. Rep."},{"key":"10.1016\/j.biopha.2024.116329_bib30","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"bmj"},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/pme.12907","article-title":"Cohort study of the impact of high-dose opioid analgesics on overdose mortality","volume":"17","author":"Dasgupta","year":"2016","journal-title":"Pain. Med."},{"key":"10.1016\/j.biopha.2024.116329_bib32","article-title":"Benzodiazepines and risk of all cause mortality in adults: cohort study","volume":"358","author":"Patorno","year":"2017","journal-title":"Bmj"},{"issue":"12","key":"10.1016\/j.biopha.2024.116329_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.28557","article-title":"Association between benzodiazepine use with or without opioid use and all-cause mortality in the United States, 1999-2015","volume":"3","author":"Xu","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.biopha.2024.116329_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132649","article-title":"A study on synthesis of benzodiazepine scaffolds using biologically active chalcones as precursors","volume":"1258","author":"Bhathiwal","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.biopha.2024.116329_bib35","series-title":"Stahl's essential psychopharmacology: neuroscientific basis and practical applications","author":"Stahl","year":"2021"},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43141-021-00224-0","article-title":"GABAA receptors: structure, function, pharmacology, and related disorders","volume":"19","author":"Ghit","year":"2021","journal-title":"J. Genet. Eng. Biotechnol."},{"issue":"48","key":"10.1016\/j.biopha.2024.116329_bib37","doi-asserted-by":"crossref","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","article-title":"Structure, function, and modulation of GABAA receptors","volume":"287","author":"Sigel","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2024.116329_bib38","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.tips.2018.03.006","article-title":"The benzodiazepine binding sites of GABAA receptors","volume":"39","author":"Sigel","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"issue":"7712","key":"10.1016\/j.biopha.2024.116329_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41586-018-0255-3","article-title":"Structure of a human synaptic GABAA receptor","volume":"559","author":"Zhu","year":"2018","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.biopha.2024.116329_bib40","doi-asserted-by":"crossref","first-page":"7139","DOI":"10.1523\/JNEUROSCI.0693-10.2010","article-title":"Amygdala-specific reduction of \u03b11-GABAA receptors disrupts the anticonvulsant, locomotor, and sedative, but not anxiolytic, effects of benzodiazepines in Mice","volume":"30","author":"Heldt","year":"2010","journal-title":"J. Neurosci."},{"issue":"17-18","key":"10.1016\/j.biopha.2024.116329_bib41","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.drudis.2009.06.009","article-title":"The complexity of the GABAA receptor shapes unique pharmacological profiles","volume":"14","author":"D\u2019Hulst","year":"2009","journal-title":"Drug Discov. Today"},{"issue":"46","key":"10.1016\/j.biopha.2024.116329_bib42","doi-asserted-by":"crossref","first-page":"10682","DOI":"10.1523\/JNEUROSCI.1166-05.2005","article-title":"Evidence for a significant role of \u03b13-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines","volume":"25","author":"Dias","year":"2005","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coph.2005.10.003","article-title":"GABA-based therapeutic approaches: GABAA receptor subtype functions","volume":"6","author":"Rudolph","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1381612023396681","article-title":"Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal","volume":"8","author":"Bateson","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2024.116329_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117033","article-title":"Flumazenil-insensitive benzodiazepine binding sites in GABAA receptors contribute to benzodiazepine-induced immobility in zebrafish larvae","volume":"239","author":"Cao","year":"2019","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.biopha.2024.116329_bib46","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1523\/JNEUROSCI.5012-10.2011","article-title":"The GABAA receptor \u03b1+ \u03b2\u2212 interface: a novel target for subtype selective drugs","volume":"31","author":"Ramerstorfer","year":"2011","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2024.116329_bib47","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3390\/brainsci10030150","article-title":"Flumazenil-insensitive benzodiazepine effects in recombinant \u03b1\u03b2 and neuronal GABAA receptors","volume":"10","author":"Lian","year":"2020","journal-title":"Brain Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15628-7","article-title":"\u03b1 subunits in GABAA receptors are dispensable for GABA and diazepam action","volume":"7","author":"Wongsamitkul","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2024.116329_bib49","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1213\/ANE.0b013e3181f9c035","article-title":"Diazepam decreases action potential firing of neocortical neurons via two distinct mechanisms","volume":"111","author":"Drexler","year":"2010","journal-title":"Anesth. Analg."},{"issue":"12","key":"10.1016\/j.biopha.2024.116329_bib50","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nrd3295","article-title":"Translocator protein (18 kDa)(TSPO) as a therapeutic target for neurological and psychiatric disorders","volume":"9","author":"Rupprecht","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5483\/BMBRep.2020.53.1.273","article-title":"Translocator protein (TSPO): the new story of the old protein in neuroinflammation","volume":"53","author":"Lee","year":"2020","journal-title":"BMB Rep."},{"key":"10.1016\/j.biopha.2024.116329_bib52","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pharmthera.2018.09.003","article-title":"TSPO in diverse CNS pathologies and psychiatric disease: A critical review and a way forward","volume":"194","author":"Guilarte","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2024.116329_bib53","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: from adaptation to disease","volume":"6","author":"De Kloet","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.biopha.2024.116329_bib54","article-title":"The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress","author":"Smith","year":"2022","journal-title":"Dialog-. Clin. Neurosci."},{"key":"10.1016\/j.biopha.2024.116329_bib55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neubiorev.2018.01.012","article-title":"High anxiety trait: a vulnerable phenotype for stress-induced depression","volume":"87","author":"Weger","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.biopha.2024.116329_bib56","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3389\/fpsyt.2020.00443","article-title":"Pharmacological treatment of anxiety disorders: the role of the HPA axis","volume":"11","author":"Tafet","year":"2020","journal-title":"Front. Psychiatry"},{"issue":"10","key":"10.1016\/j.biopha.2024.116329_bib57","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3390\/brainsci11101298","article-title":"HPA axis in the pathomechanism of depression and schizophrenia: new therapeutic strategies based on its participation","volume":"11","author":"Mikulska","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.biopha.2024.116329_bib58","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fncel.2012.00004","article-title":"The reciprocal regulation of stress hormones and GABAA receptors","volume":"6","author":"Mody","year":"2012","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.biopha.2024.116329_bib59","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/syn.890040304","article-title":"Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain","volume":"4","author":"Owens","year":"1989","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.biopha.2024.116329_bib60","first-page":"69","article-title":"New vistas in neuropeptide research in neuropsychiatry: focus on corticotropin-releasing factor. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology","volume":"6","author":"Nemeroff","year":"1992"},{"key":"10.1016\/j.biopha.2024.116329_bib61","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0022-3956(93)90029-2","article-title":"The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: implications for a role for CRF in the pathogenesis of anxiety disorders","volume":"27","author":"Owens","year":"1993","journal-title":"J. Psychiatr. Res."},{"issue":"5","key":"10.1016\/j.biopha.2024.116329_bib62","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1210\/jcem-70-5-1462","article-title":"In vitro and in vivo effects of the triazolobenzodiazepine alprazolam on hypothalamic pituitary-adrenal function: pharmacological and clinical implications","volume":"70","author":"Kalogeras","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib63","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0893-133X(89)90007-9","article-title":"Effects of chronic antidepressant and benzodiazepine treatment on corticotropin-releasing-factor receptors in rat brain and pituitary","volume":"2","author":"Grigoriadis","year":"1989","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0006-8993(88)90523-9","article-title":"Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro","volume":"463","author":"Calogero","year":"1988","journal-title":"Brain Res."},{"issue":"01","key":"10.1016\/j.biopha.2024.116329_bib65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-2007-1017143","article-title":"Benzodiazepine suppression of cortisol secretion: a measure of anxiolytic activity?","volume":"19","author":"Gram","year":"1986","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.biopha.2024.116329_bib66","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/BF03344031","article-title":"Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans","volume":"25","author":"Grottoli","year":"2002","journal-title":"J. Endocrinol. Investig."},{"issue":"10","key":"10.1016\/j.biopha.2024.116329_bib67","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.psyneuen.2006.09.009","article-title":"Attenuation of the hypothalamic\u2013pituitary\u2013adrenal axis responsivity to the Trier Social Stress Test by the benzodiazepine alprazolam","volume":"31","author":"Fries","year":"2006","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.biopha.2024.116329_bib68","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1096\/fasebj.10.4.8647351","article-title":"Modulation of the immunologic response to acute stress in humans by \u03b2-blockade or benzodiazepines","volume":"10","author":"Benschop","year":"1996","journal-title":"FASEB J."},{"issue":"04","key":"10.1016\/j.biopha.2024.116329_bib69","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-2007-1000811","article-title":"The stress-, but not corticotropin-releasing hormone-induced activation of the pituitary-adrenal axis in man is blocked by alprazolam","volume":"26","author":"Rohrer","year":"1994","journal-title":"Horm. Metab. Res."},{"issue":"4","key":"10.1016\/j.biopha.2024.116329_bib70","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.euroneuro.2008.12.004","article-title":"Alprazolam treatment immediately after stress exposure interferes with the normal HPA-stress response and increases vulnerability to subsequent stress in an animal model of PTSD","volume":"19","author":"Matar","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116329_bib71","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.2042-7158.1984.tb03014.x","article-title":"Benzodiazepine receptor antagonists reverse the effect of diazepam on plasma corticosterone in stressed rats","volume":"36","author":"Bizzi","year":"1984","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116329_bib72","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3325\/cmj.2012.53.214","article-title":"The involvement of noradrenergic mechanisms in the suppressive effects of diazepam on the hypothalamicpituitary-adrenal axis activity in female rats","volume":"53","author":"\u0160vob \u0160trac","year":"2012","journal-title":"Croat. Med. J."},{"key":"10.1016\/j.biopha.2024.116329_bib73","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF00261432","article-title":"Effects of diazepam on conflict behaviour and on plasma corticosterone levels in male and female rats","volume":"353","author":"Peri\u010di\u0107","year":"1996","journal-title":"Naunyn-Schmiede 'S. Arch. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116329_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-004-1974-8","article-title":"Cortisol response to diazepam: its relationship to age, dose, duration of treatment, and presence of generalized anxiety disorder","volume":"178","author":"Pomara","year":"2005","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.biopha.2024.116329_bib75","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.npp.1300365","article-title":"Interdose elevation in plasma cortisol during chronic treatment with alprazolam but not lorazepam in the elderly","volume":"29","author":"Pomara","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2024.116329_bib76","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11064-009-0030-9","article-title":"Cannabinoids and their interactions with diazepam on modulation of serum corticosterone concentration in male mice","volume":"35","author":"Saber-Tehrani","year":"2010","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib77","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pbb.2007.11.001","article-title":"Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice","volume":"89","author":"Naderi","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"12","key":"10.1016\/j.biopha.2024.116329_bib78","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1038\/sj.npp.1301006","article-title":"Temazepam triggers the release of vasopressin into the rat hypothalamic paraventricular nucleus: novel insight into benzodiazepine action on hypothalamic\u2013pituitary\u2013adrenocortical system activity during stress","volume":"31","author":"Welt","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2024.116329_bib79","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbi.2015.08.011","article-title":"GABAergic modulation with classical benzodiazepines prevent stress-induced neuro-immune dysregulation and behavioral alterations","volume":"51","author":"Ramirez","year":"2016","journal-title":"Brain, Behav., Immun."},{"issue":"3","key":"10.1016\/j.biopha.2024.116329_bib80","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejphar.2005.06.049","article-title":"Effects of benzodiazepines receptor agonists on the hypothalamic\u2013pituitary\u2013adrenocortical axis","volume":"519","author":"Mikkelsen","year":"2005","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116329_bib81","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/JCP.0b013e3181d41f41","article-title":"Long-term benzodiazepine use and salivary cortisol: the Netherlands Study of Depression and Anxiety (NESDA)","volume":"30","author":"Manthey","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116329_bib82","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4306\/pi.2010.7.4.251","article-title":"Epigenetic regulation of BDNF gene in response to stress","volume":"7","author":"Fuchikami","year":"2010","journal-title":"Psychiatry Investig."},{"issue":"12","key":"10.1016\/j.biopha.2024.116329_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084806","article-title":"Alterations in brain-derived neurotrophic factor in the mouse hippocampus following acute but not repeated benzodiazepine treatment","volume":"8","author":"Licata","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2024.116329_bib84","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0028-3908(99)00129-X","article-title":"Chronic modulation of the GABAA receptor complex regulates Y1 receptor gene expression in the medial amygdala of transgenic mice","volume":"39","author":"Oberto","year":"2000","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.biopha.2024.116329_bib85","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.npp.1300131","article-title":"Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic\u2013pituitary\u2013adrenal-axis activity: a placebo-controlled study","volume":"28","author":"Zwanzger","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib86","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1523\/JNEUROSCI.21-01-00262.2001","article-title":"Enhanced cortical extracellular levels of cholecystokinin-like material in a model of anticipation of social defeat in the rat","volume":"21","author":"Becker","year":"2001","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.biopha.2024.116329_bib87","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00008877-199603000-00009","article-title":"Dissociation of effects of chronic diazepam treatment and withdrawal on hippocampal dialysate 5-HT and mCPP-induced anxiety in rats","volume":"7","author":"Gibson","year":"1996","journal-title":"Behav. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116329_bib88","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0893-133X(99)00129-3","article-title":"Allostasis and allostatic load: implications for neuropsychopharmacology","volume":"22","author":"McEwen","year":"2000","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.biopha.2024.116329_bib89","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007231","article-title":"Impact of alprazolam in allostatic load and neurocognition of patients with anxiety disorders and chronic stress (GEMA): observational study protocol","volume":"5","author":"Soria","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.biopha.2024.116329_bib90","doi-asserted-by":"crossref","unstructured":"Soria C.A., Remedi C., DAlessio L., Rold\u00e1n E.J. Sex and Age-Related Differences in Neuroticism and Allostatic Load Index in Urban Patients with General Anxiety Disorder Treated with Alprazolam. 2018.","DOI":"10.1016\/j.euroneuro.2018.11.326"},{"key":"10.1016\/j.biopha.2024.116329_bib91","series-title":"Diagnostic and statistical manual of mental disorders: DSM-5","author":"American Psychiatric Association","year":"2013"},{"issue":"5","key":"10.1016\/j.biopha.2024.116329_bib92","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1378\/chest.14-0970","article-title":"International classification of sleep disorders","volume":"146","author":"Sateia","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.biopha.2024.116329_bib93","volume":"12","author":"Perlis","year":"2021","journal-title":"Why Treat. insomnia? J. Prim. Care Community Health"},{"issue":"10357","key":"10.1016\/j.biopha.2024.116329_bib94","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(22)00879-0","article-title":"Insomnia","volume":"400","author":"Perlis","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2024.116329_bib95","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.sleep.2021.01.023","article-title":"Endorsement of European guideline for the diagnosis and treatment of insomnia by the World Sleep Society","volume":"81","author":"Morin","year":"2021","journal-title":"Sleep. Med."},{"issue":"23","key":"10.1016\/j.biopha.2024.116329_bib96","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1001\/jama.2021.19283","article-title":"What Is Insomnia?","volume":"326","author":"Krystal","year":"2021","journal-title":"Jama"},{"key":"10.1016\/j.biopha.2024.116329_bib97","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2147\/CEOR.S406137","article-title":"Benzodiazepine Usage, Healthcare Resource Utilization, and Costs Among Older Adults Treated with Common Insomnia Medications: A Retrospective Cohort Study","author":"Wickwire","year":"2023","journal-title":"Clin. Outcomes Res."},{"issue":"10347","key":"10.1016\/j.biopha.2024.116329_bib98","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(22)00878-9","article-title":"Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis","volume":"400","author":"De Crescenzo","year":"2022","journal-title":"Lancet"},{"issue":"10347","key":"10.1016\/j.biopha.2024.116329_bib99","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(22)01322-8","article-title":"What is the right drug for insomnia disorder?","volume":"400","author":"Samara","year":"2022","journal-title":"Lancet"},{"issue":"10366","key":"10.1016\/j.biopha.2024.116329_bib100","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(22)02031-1","article-title":"Pharmacological interventions for insomnia disorder in adults","volume":"400","author":"Reid","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib101","first-page":"1","article-title":"Insomnia disorder","volume":"1","author":"Morin","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"11","key":"10.1016\/j.biopha.2024.116329_bib102","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/sleep\/31.11.1499","article-title":"Reduced brain GABA in primary insomnia: preliminary data from 4T proton magnetic resonance spectroscopy (1H-MRS)","volume":"31","author":"Winkelman","year":"2008","journal-title":"Sleep"},{"key":"10.1016\/j.biopha.2024.116329_bib103","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.smrv.2016.03.002","article-title":"Not a single but multiple populations of GABAergic neurons control sleep","volume":"32","author":"Luppi","year":"2017","journal-title":"Sleep. Med. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib104","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pbb.2011.12.011","article-title":"Evidence for a role of inhibition of orexinergic neurons in the anxiolytic and sedative effects of diazepam: A c-Fos study","volume":"101","author":"Panhelainen","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.biopha.2024.116329_bib105","first-page":"154","article-title":"Effects of triazolam microinjections into the peri-fornicular region on sleep in rats","volume":"5","author":"Mendelson","year":"2003","journal-title":"Sleep. Hypn."},{"issue":"15","key":"10.1016\/j.biopha.2024.116329_bib106","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/0024-3205(92)90349-T","article-title":"Characterization of the hypnotic effects of triazolam microinjections into the medial preoptic area","volume":"50","author":"Mendelson","year":"1992","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.biopha.2024.116329_bib107","doi-asserted-by":"crossref","first-page":"PL81","DOI":"10.1016\/0024-3205(93)90653-K","article-title":"Do benzodiazepines induce sleep by a GABAergic mechanism?","volume":"53","author":"Mendelson","year":"1993","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib108","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/sleep\/22.1.33","article-title":"Role of GABAA receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists","volume":"22","author":"Lancel","year":"1999","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.biopha.2024.116329_bib109","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.npp.1380110","article-title":"Dynamics of slow-wave activity and spindle frequency activity in the human sleep EEG: effect of midazolam and zopiclone","volume":"11","author":"Aeschbach","year":"1994","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.biopha.2024.116329_bib110","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-3956(00)00038-8","article-title":"Effects of hypnotics on the sleep EEG of healthy young adults: new data and psychopharmacologic implications","volume":"34","author":"Feinberg","year":"2000","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.biopha.2024.116329_bib111","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/sleep\/26.3.313","article-title":"Sleep EEG power spectra, insomnia, and chronic use of benzodiazepines","volume":"26","author":"Bastien","year":"2003","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib112","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5664\/jcsm.3354","article-title":"Polysomnographic findings in a cohort of chronic insomnia patients with benzodiazepine abuse","volume":"10","author":"Mazza","year":"2014","journal-title":"J. Clin. Sleep. Med."},{"issue":"6","key":"10.1016\/j.biopha.2024.116329_bib113","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.clinph.2017.03.009","article-title":"Sleep architecture in insomniacs with severe benzodiazepine abuse","volume":"128","author":"Manconi","year":"2017","journal-title":"Clin. Neurophysiol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib114","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.smrv.2009.04.002","article-title":"The hyperarousal model of insomnia: a review of the concept and its evidence","volume":"14","author":"Riemann","year":"2010","journal-title":"Sleep. Med. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2024.116329_bib115","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1152\/physrev.00042.2018","article-title":"Sleep spindles: mechanisms and functions","volume":"100","author":"Fernandez","year":"2020","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2024.116329_bib116","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-2869.2000.00214.x","article-title":"Functional neuroimaging of normal human sleep by positron emission tomography","volume":"9","author":"Maquet","year":"2000","journal-title":"J. Sleep. Res."},{"issue":"4","key":"10.1016\/j.biopha.2024.116329_bib117","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1176\/appi.ajp.161.4.748","article-title":"Deactivation by benzodiazepine of the basal forebrain and amygdala in normal humans during sleep: a placebo-controlled [15O] H2O PET study","volume":"161","author":"Kajimura","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.biopha.2024.116329_bib118","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bbi.2016.02.001","article-title":"Inhibiting neuroinflammation: The role and therapeutic potential of GABA in neuro-immune interactions","volume":"54","author":"Crowley","year":"2016","journal-title":"Brain, Behav., Immun."},{"key":"10.1016\/j.biopha.2024.116329_bib119","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.682612","article-title":"Diazepam impairs innate and adaptive immune responses and ameliorates experimental autoimmune encephalomyelitis","volume":"12","author":"Falc\u00f3n","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116329_bib120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000369277","article-title":"Diazepam inhibits proliferation of lymph node cells isolated from rats with experimental autoimmune encephalomyelitis","volume":"22","author":"Fern\u00e1ndez Hurst","year":"2015","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.biopha.2024.116329_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109239","article-title":"Diazepam inhibited lipopolysaccharide (LPS)-induced pyroptotic cell death and alleviated pulmonary fibrosis in mice by specifically activating GABAA receptor \u03b14-subunit","volume":"118","author":"Li","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib122","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00000542-200607000-00019","article-title":"Midazolam inhibits proinflammatory mediators in the lipopolysaccharide-activated macrophage","volume":"105","author":"Kim","year":"2006","journal-title":"J. Am. Soc. Anesthesiol."},{"key":"10.1016\/j.biopha.2024.116329_bib123","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.intimp.2018.11.050","article-title":"Midazolam suppresses the lipopolysaccharide-stimulated immune responses of human macrophages via translocator protein signaling","volume":"66","author":"Horiguchi","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116329_bib124","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.intimp.2009.11.009","article-title":"Suppressive effect of diazepam on IFN-\u03b3 production by human T cells","volume":"10","author":"Wei","year":"2010","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2024.116329_bib125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jneuroim.2017.09.012","article-title":"Diazepam treatment reduces inflammatory cells and mediators in the central nervous system of rats with experimental autoimmune encephalomyelitis","volume":"313","author":"Hurst","year":"2017","journal-title":"J. Neuroimmunol."},{"issue":"10173","key":"10.1016\/j.biopha.2024.116329_bib126","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0140-6736(18)31793-8","article-title":"Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis","volume":"393","author":"Slee","year":"2019","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.biopha.2024.116329_bib127","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1517\/14656566.2015.1059424","article-title":"Pharmacological treatment for generalized anxiety disorder in adults: an update","volume":"16","author":"Reinhold","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.biopha.2024.116329_bib128","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-066084","article-title":"Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials","volume":"376","author":"Chawla","year":"2022","journal-title":"bmj"},{"issue":"7","key":"10.1016\/j.biopha.2024.116329_bib129","first-page":"Cd007139","article-title":"Alprazolam for depression","author":"van Marwijk","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2024.116329_bib130","first-page":"Cd001026","article-title":"Antidepressants plus benzodiazepines for adults with major depression","volume":"6","author":"Ogawa","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.biopha.2024.116329_bib131","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/JCP.0000000000000740","article-title":"A 6-Year Posttreatment Follow-up of Panic Disorder Patients: Treatment With Clonazepam Predicts Lower Recurrence Than Treatment With Paroxetine","volume":"37","author":"Freire","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"issue":"10277","key":"10.1016\/j.biopha.2024.116329_bib132","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0140-6736(21)00359-7","article-title":"Anxiety disorders","volume":"397","author":"Penninx","year":"2021","journal-title":"Lancet"},{"issue":"10295","key":"10.1016\/j.biopha.2024.116329_bib133","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(21)00934-X","article-title":"Benzodiazepines for the long-term treatment of anxiety disorders?","volume":"398","author":"Tibrewal","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.biopha.2024.116329_bib134","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/02698811211069096","article-title":"Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: A population-based cohort study","volume":"36","author":"Davies","year":"2022","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib135","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.biopsych.2009.01.023","article-title":"Co-treatment with diazepam prevents the effects of fluoxetine on the proliferation and survival of hippocampal dentate granule cells","volume":"66","author":"Wu","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2024.116329_bib136","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neuropharm.2013.04.021","article-title":"A benzodiazepine impairs the neurogenic and behavioural effects of fluoxetine in a rodent model of chronic stress","volume":"72","author":"Sun","year":"2013","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.biopha.2024.116329_bib137","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1177\/0004867415590631","article-title":"Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression","volume":"49","author":"Ford","year":"2015","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.biopha.2024.116329_bib138","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/JCP.0000000000000316","article-title":"Concomitant benzodiazepine use attenuates ketamine response: implications for large scale study design and clinical development","volume":"35","author":"Frye","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib139","doi-asserted-by":"crossref","first-page":"43883","DOI":"10.4088\/JCP.22m14491","article-title":"Effect of concomitant benzodiazepines on the antidepressant effects of ketamine: findings from the RAPID intravenous ketamine study","volume":"84","author":"Feeney","year":"2022","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.biopha.2024.116329_bib140","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41380-018-0310-3","article-title":"Central amygdala circuit dynamics underlying the benzodiazepine anxiolytic effect","volume":"26","author":"Griessner","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"21","key":"10.1016\/j.biopha.2024.116329_bib141","doi-asserted-by":"crossref","first-page":"11781","DOI":"10.1073\/pnas.1920147117","article-title":"Common and dissociable effects of oxytocin and lorazepam on the neurocircuitry of fear","volume":"117","author":"Kreuder","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2024.116329_bib142","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.biopsych.2018.09.024","article-title":"Gephyrin palmitoylation in basolateral amygdala mediates the anxiolytic action of benzodiazepine","volume":"85","author":"Shen","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.biopha.2024.116329_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148481","article-title":"Diazepam promotes active avoidance extinction associating with increased dorsal CA3 and amygdala activity","volume":"1817","author":"Zhang","year":"2023","journal-title":"Brain Res."},{"issue":"3-4","key":"10.1016\/j.biopha.2024.116329_bib144","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000454881","article-title":"Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis","volume":"47","author":"Islam","year":"2017","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.biopha.2024.116329_bib145","doi-asserted-by":"crossref","first-page":"g5205","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study","volume":"349","author":"De Gage","year":"2014","journal-title":"Bmj"},{"key":"10.1016\/j.biopha.2024.116329_bib146","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s40264-015-0319-3","article-title":"Benzodiazepine use and risk of developing Alzheimer\u2019s disease or vascular dementia: a case\u2013control analysis","volume":"38","author":"Imfeld","year":"2015","journal-title":"Drug Saf."},{"issue":"6","key":"10.1016\/j.biopha.2024.116329_bib147","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1176\/appi.ajp.2020.20040375","article-title":"Do Benzodiazepines Cause Alzheimer's Disease?","volume":"177","author":"Salzman","year":"2020","journal-title":"Am. J. Psychiatry"},{"issue":"9390","key":"10.1016\/j.biopha.2024.116329_bib148","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0140-6736(03)14469-8","article-title":"Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study","volume":"362","author":"Chan","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2024.116329_bib149","doi-asserted-by":"crossref","first-page":"i90","DOI":"10.1136\/bmj.i90","article-title":"Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study","volume":"352","author":"Gray","year":"2016","journal-title":"Bmj"},{"issue":"6","key":"10.1016\/j.biopha.2024.116329_bib150","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1176\/appi.ajp.2019.19030315","article-title":"Associations of Benzodiazepines, Z-Drugs, and Other Anxiolytics With Subsequent Dementia in Patients With Affective Disorders: A Nationwide Cohort and Nested Case-Control Study","volume":"177","author":"Osler","year":"2020","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib151","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s13311-019-00801-9","article-title":"Benzodiazepines, z-Hypnotics, and Risk of Dementia: Special Considerations of Half-Lives and Concomitant Use","volume":"17","author":"Tseng","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"6","key":"10.1016\/j.biopha.2024.116329_bib152","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40263-018-0535-3","article-title":"A Systematic Review and Meta-Analysis of the Risk of Dementia Associated with Benzodiazepine Use, After Controlling for Protopathic Bias","volume":"32","author":"Penninkilampi","year":"2018","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.biopha.2024.116329_bib153","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bbrc.2015.01.022","article-title":"Midazolam inhibits the formation of amyloid fibrils and GM1 ganglioside-rich microdomains in presynaptic membranes through the gamma-aminobutyric acid A receptor","volume":"457","author":"Yamamoto","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.biopha.2024.116329_bib154","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0306-4522(00)00144-5","article-title":"Benzodiazepines protect hippocampal neurons from degeneration after transient cerebral ischemia: an ultrastructural study","volume":"98","author":"Schwartz-Bloom","year":"2000","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.biopha.2024.116329_bib155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bbr.2011.12.013","article-title":"Beneficial effects of benzodiazepine diazepam on chronic stress-induced impairment of hippocampal structural plasticity and depression-like behavior in mice","volume":"228","author":"Zhao","year":"2012","journal-title":"Behav. brain Res."},{"key":"10.1016\/j.biopha.2024.116329_bib156","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2018.10.027","article-title":"Administration of the benzodiazepine midazolam increases tau phosphorylation in the mouse brain","volume":"75","author":"Whittington","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.biopha.2024.116329_bib157","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pbb.2018.07.005","article-title":"Chronic benzodiazepine suppresses translocator protein and elevates amyloid \u03b2 in mice","volume":"172","author":"Tan","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2024.116329_bib158","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuro.2022.08.003","article-title":"Novel benzodiazepine remimazolam tosylate delays neurodegeneration of aged mice via decreasing tau phosphorylation","volume":"92","author":"Liu","year":"2022","journal-title":"Neurotoxicology"},{"issue":"45","key":"10.1016\/j.biopha.2024.116329_bib159","doi-asserted-by":"crossref","first-page":"9350","DOI":"10.1523\/JNEUROSCI.0335-21.2021","article-title":"Dynamic Recovery: GABA Agonism Restores Neural Variability in Older, Poorer Performing Adults","volume":"41","author":"Lalwani","year":"2021","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.biopha.2024.116329_bib160","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/brain.2020.0844","article-title":"Mapping the Synchronization Effect of Gamma-Aminobutyric Acid Inhibition on the Cerebral Cortex Using Magnetic Resonance Imaging","volume":"11","author":"Blanco-Hinojo","year":"2021","journal-title":"Brain Connect"},{"issue":"8326 Pt 1","key":"10.1016\/j.biopha.2024.116329_bib161","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0140-6736(83)92012-3","article-title":"Do benzodiazepines cause cerebral atrophy?","volume":"1","author":"Poser","year":"1983","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib162","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00004714-200002000-00002","article-title":"Long-term benzodiazepine therapy does not result in brain abnormalities","volume":"20","author":"Busto","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib163","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1017\/S0033291700003214","article-title":"Computed axial brain tomography in long-term benzodiazepine users","volume":"14","author":"Lader","year":"1984","journal-title":"Psychol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2024.116329_bib164","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0165-1781(93)90037-H","article-title":"Computed axial brain tomograms in long-term benzodiazepine users","volume":"48","author":"Moodley","year":"1993","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.biopha.2024.116329_bib165","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1017\/S0033291700026003","article-title":"Computerized axial tomographic studies following long-term use of benzodiazepines","volume":"17","author":"Perera","year":"1987","journal-title":"Psychol. Med."},{"issue":"11","key":"10.1016\/j.biopha.2024.116329_bib166","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jagp.2016.04.013","article-title":"Benzodiazepine use attenuates cortical \u03b2-Amyloid and is not associated with progressive cognitive decline in nondemented elderly adults: a pilot study using F18-Florbetapir positron emission tomography","volume":"24","author":"Chung","year":"2016","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.biopha.2024.116329_bib167","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2019.08.008","article-title":"Benzodiazepine use and brain amyloid load in nondemented older individuals: a florbetapir PET study in the Multidomain Alzheimer Preventive Trial cohort","volume":"84","author":"Desmidt","year":"2019","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.biopha.2024.116329_bib168","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41386-021-01246-5","article-title":"Benzodiazepine use and neuroimaging markers of Alzheimer\u2019s disease in nondemented older individuals: an MRI and 18F Florbetapir PET study in the MEMENTO cohort","volume":"47","author":"Gallet","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib169","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40263-015-0305-4","article-title":"The Benzodiazepine-Dementia Disorders Link: Current State of Knowledge","volume":"30","author":"Pariente","year":"2016","journal-title":"CNS Drugs"},{"issue":"12","key":"10.1016\/j.biopha.2024.116329_bib170","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1056\/NEJMra1611832","article-title":"Treatment of benzodiazepine dependence","volume":"376","author":"Soyka","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2024.116329_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108061","article-title":"Benzodiazepine misuse in adults with alcohol use disorder: Prevalence, motives and patterns of use","volume":"117","author":"McHugh","year":"2020","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.biopha.2024.116329_bib172","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.1060949","article-title":"GABAA receptor subtypes and benzodiazepine use, misuse, and abuse","volume":"13","author":"Engin","year":"2023","journal-title":"Front. Psychiatry"},{"issue":"10","key":"10.1016\/j.biopha.2024.116329_bib173","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1016\/j.addbeh.2013.06.010","article-title":"Clusters of personality traits and psychological symptoms associated with later benzodiazepine prescriptions in the general population: The HUNT Cohort Study","volume":"38","author":"Nordfj\u00e6rn","year":"2013","journal-title":"Addict. Behav."},{"key":"10.1016\/j.biopha.2024.116329_bib174","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.886704","article-title":"The ventral tegmental area and nucleus accumbens as circadian oscillators: implications for drug abuse and substance use disorders","volume":"13","author":"Becker-Krail","year":"2022","journal-title":"Front. Physiol."},{"issue":"7282","key":"10.1016\/j.biopha.2024.116329_bib175","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nature08758","article-title":"Neural bases for addictive properties of benzodiazepines","volume":"463","author":"Tan","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.116329_bib176","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s002130050356","article-title":"Effects of lorazepam administration on striatal dopamine D2 receptor binding characteristics in man\u2013a positron emission tomography study","volume":"132","author":"Hietala","year":"1997","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.biopha.2024.116329_bib177","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pscychresns.2009.04.006","article-title":"The effects of lorazepam on extrastriatal dopamine D2\/3-receptors\u2014A double-blind randomized placebo-controlled PET study","volume":"174","author":"Vilkman","year":"2009","journal-title":"Psychiatry Res.: Neuroimaging"},{"issue":"9","key":"10.1016\/j.biopha.2024.116329_bib178","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/mp.2012.139","article-title":"Oral alprazolam acutely increases nucleus accumbens perfusion","volume":"18","author":"Wolf","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib179","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1124\/jpet.117.241802","article-title":"Diazepam concurrently increases the frequency and decreases the amplitude of transient dopamine release events in the nucleus accumbens","volume":"364","author":"Schelp","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2024.116329_bib180","article-title":"Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users","author":"Baandrup","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2024.116329_bib181","doi-asserted-by":"crossref","first-page":"152","DOI":"10.18773\/austprescr.2015.055","article-title":"Management of benzodiazepine misuse and dependence","volume":"38","author":"Brett","year":"2015","journal-title":"Aust. Prescr."},{"key":"10.1016\/j.biopha.2024.116329_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2022.101605","article-title":"A systematic scoping review of the effects of central nervous system active drugs on sleep spindles and sleep-dependent memory consolidation","volume":"62","author":"Leong","year":"2022","journal-title":"Sleep. Med. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2024.116329_bib183","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1037\/a0028830","article-title":"Sleep, memory, and aging: the link between slow-wave sleep and episodic memory changes from younger to older adults","volume":"28","author":"Scullin","year":"2013","journal-title":"Psychol. Aging"},{"issue":"5","key":"10.1016\/j.biopha.2024.116329_bib184","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsz280","article-title":"Self-reported sleep relates to hippocampal atrophy across the adult lifespan: results from the Lifebrain consortium","volume":"43","author":"Fjell","year":"2020","journal-title":"Sleep"},{"issue":"10","key":"10.1016\/j.biopha.2024.116329_bib185","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/s41386-020-0720-1","article-title":"Diazepam limits microglia-mediated neuronal remodeling in the prefrontal cortex and associated behavioral consequences following chronic unpredictable stress","volume":"45","author":"Bollinger","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.biopha.2024.116329_bib186","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41593-022-01013-9","article-title":"Long-term diazepam treatment enhances microglial spine engulfment and impairs cognitive performance via the mitochondrial 18 kDa translocator protein (TSPO)","volume":"25","author":"Shi","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.biopha.2024.116329_bib187","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.4103\/1673-5374.310608","article-title":"Neuroimmune connections between corticotropin-releasing hormone and mast cells: novel strategies for the treatment of neurodegenerative diseases","volume":"16","author":"Bhuiyan","year":"2021","journal-title":"Neural Regen. Res."},{"issue":"12","key":"10.1016\/j.biopha.2024.116329_bib188","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.3390\/molecules28124771","article-title":"Synthesis and receptor binding studies of \u03b15 GABAAR selective novel imidazodiazepines targeted for psychiatric and cognitive disorders","volume":"28","author":"Sharmin","year":"2023","journal-title":"Molecules"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224002130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224002130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:07:43Z","timestamp":1793786863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224002130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":188,"alternative-id":["S0753332224002130"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116329","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring clinical applications and long-term effectiveness of benzodiazepines: An integrated perspective on mechanisms, imaging, and personalized medicine","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116329"}}